Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyamine oxidase activity in rats treated with mitoguazone: specific and permanent decrease in thymus.

M E Ferioli1, A Armanni

  • 1Centro di Studio sulla Patologia Cellulare, C.N.R, c/o Istituto di Patologia Generale, Università di Milano, Milan, Italy. MariaElena.Ferioli@unimi.it

Amino Acids
|March 8, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Administration of the antitumor drug mitoguazone protects normal thymocytes against spontaneous and etoposide-induced apoptosis.

Cellular and molecular life sciences : CMLS·2004
Same author

Prolactin and polyamine catabolism: specific effect on polyamine oxidase activity in rat thymus.

Molecular and cellular endocrinology·2000
Same author

Polyamine oxidase activity in lymphoid tissues of glucocorticoid-treated rats.

Biochemical pharmacology·1999
Same author

Gender-related differences in polyamine oxidase activity in rat tissues.

Amino acids·1999
Same author

Changes in hepatic polyamine catabolism in elderly rats.

Liver·1998
Same author

Aging and polyamine acetylation in rat kidney.

Biochimica et biophysica acta·1996
Same journal

Author Correction: Novel octapeptide containing the RGD sequence as a potential anti-SARS-CoV-2 agent: design, synthesis, and theoretical studies.

Amino acids·2026
Same journal

Polyamines in CNS malignancies: positively charged culprits in the hijacking of neural and immune signaling pathways.

Amino acids·2026
Same journal

The effects of glutamine supplementation on inflammatory and oxidative stress indices in chronic diseases: a systematic review.

Amino acids·2026
Same journal

Reprogramming parasitic signatures into anticancer peptide candidates: in silico discovery of Leishmania major-derived peptides.

Amino acids·2026
Same journal

Effects of taurine on skeletal muscle in senescence-accelerated mice and C2C12 myoblasts and myotubes.

Amino acids·2026
Same journal

Dual functions of thermospermine in plant growth and stress responses.

Amino acids·2026
See all related articles

Mitoguazone drug reduces polyamine oxidase activity and hydrogen peroxide in the thymus, potentially improving immune function in patients with AIDS-related diseases.

Area of Science:

  • Biochemistry
  • Immunology
  • Pharmacology

Background:

  • Polyamines are crucial for cell growth and function.
  • Polyamines are metabolized by polyamine oxidase, producing hydrogen peroxide.
  • Hydrogen peroxide can induce apoptosis, impacting thymus physiology.

Purpose of the Study:

  • To investigate the effect of mitoguazone on polyamine oxidase activity in the thymus.
  • To explore the relationship between polyamine oxidase inhibition and thymus physiology.
  • To assess the potential of mitoguazone in modulating thymus function for therapeutic benefit.

Main Methods:

  • Administration of mitoguazone, a polyamine biosynthetic pathway inhibitor.
  • Measurement of polyamine oxidase enzyme activity in thymus tissue.

Related Experiment Videos

  • Quantification of putrescine levels in the thymus.
  • Assessment of thymus physiology changes post-treatment.

    • Main Results:

    • Mitoguazone significantly and permanently decreased polyamine oxidase activity in the thymus.
    • Putrescine levels were reduced in the thymus over time.
    • Reduced polyamine oxidase activity correlated with a positive effect on thymus physiology.

    Conclusions:

    • Mitoguazone effectively inhibits polyamine oxidase in the thymus.
    • Reduced hydrogen peroxide production due to lower polyamine oxidase activity may benefit thymus physiology.
    • The thymus is a potential target organ for mitoguazone, contributing to its efficacy in AIDS-related diseases.